1973 …2017

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Biography

Alec Morley retired from full university duties in 2004.   He now works part-time and leads a research group which is investigating the application of molecular genetics to medical, particularly haematological, disorders.   The most active area of research activity is the development and application of molecular methods for measurement of minimal residual disease in haematological cancers, but the group is also involved in the development of several other new molecular diagnostic techniques.

Professor Morley is also involved in the commercialisation of potentially useful items of intellectual property which have resulted from the research activities of the group

Fingerprint Dive into the research topics where Alec Morley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCR.

Kommers, I., Bartley, P., Budgen, B., Latham, S., Beligaswatte, A., Supple, S., Catalano, A., Iland, H., Morley, A. & Ross, D., 2017, In : Leukemia and Lymphoma. 58, 7, p. 1767-1769 3 p.

Research output: Contribution to journalArticle

Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia

Latham, S., Hughes, E., Budgen, B., Mechinaud, F., Crock, C., Ekert, H., Campbell, P. & Morley, A., 2017, In : PLoS One. 12, 10, 10 p., e0185556.

Research output: Contribution to journalArticle

  • BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemia

    Latham, S., Bartley, P., Budgen, B., Ross, D., Hughes, E., Branford, S., White, D., Hughes, T. & Morley, A., Sep 2016, In : Journal of Molecular Diagnostics. 69, 9, p. 817-821 5 p.

    Research output: Contribution to journalArticle

  • 4 Citations (Scopus)

    Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia

    Bradstock, K. F., Morley, A., Byth, K., Szer, J., Prosser, I., Cannell, P., Irving, I. & Seymour, J. F., 15 Dec 2016, In : Contemporary Clinical Trials Communications. 4, p. 9-13 5 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)

    Reporting results for deep molecular responses in chronic myeloid leukemia

    Morley, A. A., Jul 2016, In : Leukemia. 30, 7, p. 1630-1631 2 p.

    Research output: Contribution to journalLetter

  • 2 Citations (Scopus)